gut bacterium

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

  • Patrice D. Cani
  • Clara Depommier
  • Willem M. de Vos
Review Article

Announcements

  • Image shows organs, neurons and microbes in the spotlight

    Leading experts describe their key advances of the year. Topics covered include: IBD; liver cancer; enteric nervous system; viral hepatitis; liver fibrosis; gut mycobiota; colorectal cancer.

  • Image of face mask and glove

    FREE ACCESS - This Collection covers the COVID-19 pandemic and its implications for patients with gastrointestinal and liver diseases.

  • Image of Nature Reviews Gastro twitter logo

    Follow us for news about the journal and the latest updates from the gastroenterology and hepatology field.

Advertisement

series of fatty livers on a yellow background

NAFLD and NASH

Fuelled by increasing obesity rates, NAFLD has emerged as a leading global cause of chronic liver disease in the past few decades. Despite growing prevalence, the factors influencing NAFLD development and subsequent progression to NASH, liver fibrosis, cirrhosis and hepatocellular carcinoma are poorly understood. In this article series, Nature Reviews Gastroenterology & Hepatology explores the epidemiology of NAFLD, disease mechanisms and therapeutics, and clinical approaches to diagnosis and management.
  • Hugh Thomas
Series

Advertisement

Nature Careers

Events

Jobs

Advertisement